VENUS MEDTECH (HANGZHOU) INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.62 HKD | -0.71% |
|
-.--% | -.--% |
| 04-01 | Venus Medtech Trims Loss in 2023 as Revenue Grows Nearly 21% | MT |
| 03-28 | Venus Medtech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on Venus Medtech (Hangzhou) Inc.
Price target over the last 5 years
History of analyst recommendation changes
97501ca088c91676baa.8mkqY6pTuPQnT3Fc6QIL0mb2B48Hl7vYfWm8--W0Frs.xhF-KsIM-pBDfRwUrU1O4grPbbhr2-TgLgbotIODI-KEOWZQ-gTqvHN7IA~815369c9d3c58f47bd437ca22ae4d2ab
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
5.157
CNY
Average target price
7.414
CNY
Spread / Average Target
+43.78%
High Price Target
11.03
CNY
Spread / Highest target
+113.98%
Low Price Target
3.73
CNY
Spread / Lowest Target
-27.67%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
B
EPS Revisions
- Stock Market
- Equities
- 2500 Stock
- Consensus Venus Medtech (Hangzhou) Inc.
